These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [An experimental study on bladder carcinogenesis in dogs by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and its urinary metabolites]. Morishita S; Hamami G; Kamidono S Hinyokika Kiyo; 1989 Jan; 35(1):27-38. PubMed ID: 2729018 [TBL] [Abstract][Full Text] [Related]
43. Ascorbic acid and the formation of N-nitroso compounds: possible role of ascorbic acid in cancer prevention. Kyrtopoulos SA Am J Clin Nutr; 1987 May; 45(5 Suppl):1344-50. PubMed ID: 3578122 [No Abstract] [Full Text] [Related]
44. Dietary exposure and urinary excretion of total N-nitroso compounds, nitrosamino acids and volatile nitrosamine in inhabitants of high- and low-risk areas for esophageal cancer in southern China. Lin K; Shen W; Shen Z; Wu Y; Lu S Int J Cancer; 2002 Nov; 102(3):207-11. PubMed ID: 12397637 [TBL] [Abstract][Full Text] [Related]
45. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Milner JA Adv Exp Med Biol; 2001; 492():69-81. PubMed ID: 11480676 [TBL] [Abstract][Full Text] [Related]
46. Recent studies on N-nitroso compounds as possible etiological factors in oesophageal cancer. Lu SH; Ohshima H; Bartsch H IARC Sci Publ; 1984; (57):947-53. PubMed ID: 6533080 [TBL] [Abstract][Full Text] [Related]
48. Tumor induction in a rat model for ureterosigmoidostomy without evidence of nitrosamine formation. Kälble T; Tricker AR; Berger M; Amelung F; Waldherr R; Hothorn L; Möhring K; Staehler G J Urol; 1991 Sep; 146(3):862-6. PubMed ID: 1714971 [TBL] [Abstract][Full Text] [Related]
49. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis. Suzuki E; Anjo T; Aoki J; Okada M Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438 [TBL] [Abstract][Full Text] [Related]
50. N-Nitroso compounds and human cancer. A molecular epidemiologic approach. Choi BC Am J Epidemiol; 1985 May; 121(5):737-43. PubMed ID: 4014165 [TBL] [Abstract][Full Text] [Related]
52. Endogenous formation of N-nitroso compounds: a current perspective. Tannenbaum SR IARC Sci Publ; 1987; (84):292-6. PubMed ID: 3679388 [TBL] [Abstract][Full Text] [Related]
53. Urinary N-nitrosamino acids as an index of exposure to N-nitroso compounds. Ohshima H; Bartsch H IARC Sci Publ; 1988; (89):83-91. PubMed ID: 3198235 [TBL] [Abstract][Full Text] [Related]
54. Association of cigarette smoking and nitrosamines with urinary bladder cancer: a review. Nomura AM Natl Cancer Inst Monogr; 1982; 62():185-90. PubMed ID: 7167187 [TBL] [Abstract][Full Text] [Related]
55. [Bacterial formation and degradation of a nitrosamine, paranitrosodimethylaniline]. Hau HC; Jacquet J; Prévot AR C R Acad Hebd Seances Acad Sci D; 1973 Feb; 276(9):1507-8. PubMed ID: 4198630 [No Abstract] [Full Text] [Related]
56. Gastric juice N-nitrosamines in health and gastroduodenal disease. Reed PI; Smith PL; Haines K; House FR; Walters CL Lancet; 1981 Sep; 2(8246):550-2. PubMed ID: 6116002 [TBL] [Abstract][Full Text] [Related]
57. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder. Suzuki E; Iiyoshi M; Okada M Gan; 1981 Feb; 72(1):113-22. PubMed ID: 7274637 [TBL] [Abstract][Full Text] [Related]
58. Carcinogenicity test of two unstaurated derivatives of N-nitrosopiperdine in Sprague-Dawley rats. Lijinsky W; Taylor HW J Natl Cancer Inst; 1976 Dec; 57(6):1315-7. PubMed ID: 187801 [TBL] [Abstract][Full Text] [Related]
59. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Rivenson A; Hoffmann D; Prokopczyk B; Amin S; Hecht SS Cancer Res; 1988 Dec; 48(23):6912-7. PubMed ID: 3180100 [TBL] [Abstract][Full Text] [Related]